(Q39833455)

15 September 2017

title

Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity (English)

1 reference

15 September 2017

A A Hombach

1

1 reference

15 September 2017

D Kofler

series ordinal

2

1 reference

15 September 2017

G Rappl

series ordinal

3

1 reference

15 September 2017

H Abken

series ordinal

4

1 reference

15 September 2017

publication date

25 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

9

1 reference

15 September 2017

page(s)

1088-1096

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2009.75

15 September 2017

exact match

0 references

cites work

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Tissue carcinoembryonic antigen and DNA aneuploidy in precancerous and cancerous colorectal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

7 January 2021

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

7 January 2021

Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

7 January 2021

Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

7 January 2021

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.75

7 January 2021

Identifiers

DOI

10.1038/GT.2009.75

1 reference

Dimensions Publication ID

15 September 2017

1023836692

0 references

1 reference